2010
BioGeneration leads large syndicate in first round investment in Arcarios BV - 25 August 2010
TiGenix announces spin-out of its targeted drug discovery activities in newco Arcarios - 24 August 2010
BioCeros and Prima Biomed (AUS) announce licensing agreement for Cripto-1 cancer immunotherapy treatment - 17 August 2010
arGEN-X granted broad patent covering its unique SIMPLE Antibody™ platform – 8 July 2010
Mucosis receives financial support from the Dutch government for its FluGEM™program – 31 May 2010
Mucosis appoints Dr. Roberto Grimaldi as Chief Medical Officer – 27 April 2010
2009
Medisse announces closure of a financing round by BioGeneration Ventures and Crédit Agricole Private Equity - 10 December 2009
Mucosis receives key US patent covering its Mimopath (tm) Technology - 22 September 2009
arGEN-X raises €9.5 million to put SIMPLE Antibody™ platform to work - 10 September 2009
FlexGen announced today the closure of an equity financing round by BioGeneration Ventures and Crédit Agricole Private Equity - 2 March 2009
DSM and Crucell Sign Agreement with Bioceros ... - 10 February 2009
Mucosis B.V. and PATH start development of pneumococcal vaccines - 28 January 2009
Progentix Orthobiology and NuVasive Sign Investment Agreement - 14 January 2009
NuVasive Announces Investment in Novel Orthobiologic Company - 13 January 2009
2008
Mucosis B.V. and TNO announce flu vaccine research and development partnership - 15 December 2008
Mucosis B.V. appoints Dr. Govert Schouten as CEO - 6 November 2008
Bioceros B.V. closes first financing round - 21 September 2008
Progentix Orthobiology B.V. closes Series A financing round - 21 January 2008
NovioGendix closes Series A Financing Round - 21 January 2008
2007
Mucosis raises € 3 million in first financing round - 10 September 2007
Forbion Capital Partners spins out of ABN AMRO Capital - 08 January 2007
2006
First closing of BioGeneration Ventures Fund - 17 November 2006
|
